This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin is as effective as standard dose chemotherapy in the induction treatment for patients aged from 55 to 69 years old with newly diagnosed acute myeloid leukemia
- Jiayu Huang, Ming Hong, Yu Zhu, Huihui Zhao, Xiaoyan Zhang, Yujie Wu, Yun Lian, Xiaoli Zhao, Jianyong Li, Sixuan Qian
- Leukemia & Lymphoma, April 2018, Taylor & Francis
- DOI: 10.1080/10428194.2018.1443328
